DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20172466

The seroprevalence of HIV, hepatitis B, hepatitis C and venereal disease research laboratory test seropositivity in blood donors: a 5-year retrospective comparative study at tertiary care hospital in Mumbai, Maharashtra, India

Khaneta Parveen, Abdul Faheem Khan, Abdul Salim Khan

Abstract


Background: The high seroprevalence of transfusion-transmitted infectious (TTI) diseases such as HIV, hepatitis B virus (HBV), hepatitis C virus (HCV) and syphilis in India affects the safety of blood for recipients. This study was undertaken with the aim to screen the blood donor’s demographic profile and to estimate seroprevalence of HIV, HBV, HCV and VDRL transmissible by blood transfusion in voluntary and replacement male and female blood donors during the last 5 year period.

Methods: The present study was conducted over a period of 5 years (2001-2005) and involved 1,53,020 blood donors including both (voluntary, replacement males and females) who were thoroughly screened and selected for blood donation in blood bank at Departments of Pathology, Seth GS Medical College and KEM hospital, Mumbai, Maharashtra, India.

Results: Total five years seropositivity for all four disease marker in all blood donors was 9150 (5.97%). The incidence of HIV seropositivity was 1995 (1.30%), the seroprevalence of HBV in total blood donor was 4673 (3.05%), HCV consist of 1599 (1.04%), and VDRL seropositivity was least, i.e. 883 (0.57%). Out of total 9150 (5.97%) seropositive blood donors, 24 (0.26%) blood donors showed concomitant seropositivity for more than one of the blood transmissible diseases.

Conclusions: Seroprevalence rate of all the four blood transmissible diseases was higher in replacement donors, and lower in voluntary group of donors. Therefore, it has been evaluated that the voluntary blood donation is safer and promoted for safe blood donation in comparison to replacement blood donation.


Keywords


Blood donors, HIV, Replacement, Seropositive, Voluntary

Full Text:

PDF

References


Blood safety and availability. Fact sheet. Available from: http:// www.who.int/ mediacentre/ factsheets/ fs279/en/

WHO Global Database on Blood Safety, 2004-2005. Geneva. World Health Organization. 2008.

NACO - Modules for Medical Officers on HIV Care and Treatment (including ART) curriculum. Participants Guide. 2007.

WHO - Towards 100% Voluntary Blood Donation. A Global Framework for Action. 2010.

Singh B, Verma M, Verma K. Markers for transfusion-associated hepatitis in North Indian blood donors: prevalence and trends. Japan J Infect Dis. 2004;57:49-51.

Matee MI, Magesa PM, Lyamuya EF. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam (MUHS), Tanzania. BMC Public Health. 2006;6(1):21.

Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion-transmissible infections in north Indian voluntary and replacement blood donors: Prevalence and trends 1989-1996. Vox Sang. 1997;73:70-3.

Mundee Y, Kamtorn N, Infectious disease markers in blood donors in Northern Thailand. Transfusion. 1995;35(3):264-7.

Makroo RN, SaIiI P, Vashist RP, Shiv LaI. Trends of HIV infection in blood donors of Delhi. Indian J Pathol Microbiol. 1996;39:139-42.

Garg S, Mathur DR, Garg DK. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India. Indian J Pathol Microbiol. 2001;44(4):409-12.

Shimoyama R, Kato T, Ikeda H, Sekiguchi S. Follow-Up to HBV and HCV carriers in a Blood center. Vox sanguinis. 1998;75(3):257-8.

Kunasol P. Thailand: more than 6,00,000 HIV infections. AIDS Asia. 1994;3:12.

Sawanpanyalert P, Uthaivoravit W, Yanai H, Limpakarnjanarat K, Mastro TD, Nelson KE. Donation deferral criteria for human immunodeficiency virus positivity among blood donors in northern Thailand. Transfusion. 1996;36(3):242-9.

Kagu MB, Kawuwa MB, Ayilara AO, Ali BZ. Seroprevalence of HIV and hepatitis viruses in directed blood donors: a preliminary report. Highland Med Res J. 2005;3(2):76-80.

Sharma RR, Cheema R, Vajpayee M, Rao U, Kumar S, Marwaha N, et al. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement donors. Nail Med J India. 2004;17:19-21.

Kapoor D, Saxena R, Sood B, Sarin SK. Blood transfusion practices in India: results of a national survey. Indian J Gastroenterol. 2000;19(2):64-7

Singhvi A, Pulimood RB. The prevalence of markers for hepatitis B and human immunodeficiency viruses, malarial parasites and microfilaria in blood donors in a large hospital in south India. J Trop Med Hyg. 1990;93(3):178-82.

Sarkodie F, Adarkwa M. Screening for viral markers in volunteer and replacement blood donors in West Africa. Vox Sang. 2001;80(3):142-7.

Arya DR. A comparative study of seropositivity of HIV infection amongst the voluntary and replacement blood donors in western Rajasthan in India. Int Conf AIDS; 2004:15.